文献速递白血病

基因表达特征可预测细胞遗传学正常成人急性髓系白血病复发

Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia.
PubMed 文献 · Blood Adv · 2021-01-01

研究对268例接受标准「7+3」诱导化疗后达完全缓解的60岁以下初诊细胞遗传学正常急性髓系白血病成人患者进行RNA测序,在过滤与CEBPA、NPM1和FLT3-ITD突变相关基因后,识别出10基因特征可强预测复发(AUC 0.81),并在TCGA独立队列验证(AUC 0.78)。

要点

  • 10基因特征在调整FLT3-ITD、CEBPA、NPM1突变状态后仍与复发强相关(P < .001)。
  • 该特征由7个编码基因和3个长链非编码RNA组成。
  • 在TCGA独立患者集中验证显示强预测价值(AUC = 0.78)。

核心结论

  • 10基因表达特征可强预测细胞遗传学正常成人急性髓系白血病患者复发,有助于临床预后分层。

研究设计与样本

  • 对268例60岁以下初诊细胞遗传学正常急性髓系白血病成人患者诱导前样本行RNA测序,患者接受标准「7+3」化疗后达完全缓解。

主要发现

  • 10基因特征预测复发AUC为0.81。
  • 多因素分析调整FLT3-ITD、CEBPA、NPM1突变状态后,10基因特征与复发强相关(P < .001)。
  • 在TCGA独立患者集中验证,AUC = 0.78。

关键数值与推荐

  • 10基因特征由7个编码基因(GAS6、PSD3、PLCB4、DEXI、JMY、NRP1、C10orf55)和3个长链非编码RNA组成。

临床怎么用

  • 将10基因特征纳入临床预后分层可能有助于识别可能复发的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Although ∼80% of adult patients with cytogenetically normal acute myeloid leukemia (CN-AML) achieve a complete remission (CR), more than half of them relapse. Better identification of patients who are likely to relapse can help to inform clinical decisions. We performed RNA sequencing on pretreatment samples from 268 adults with de novo CN-AML who were younger than 60 years of age and achieved a CR after induction treatment with standard "7+3" chemotherapy. After filtering for genes whose expressions were associated with gene mutations known to impact outcome (ie, CEBPA, NPM1, and FLT3-internal tandem duplication [FLT3-ITD]), we identified a 10-gene signature that was strongly predictive of patient relapse (area under the receiver operating characteristics curve [AUC], 0.81). The signature consisted of 7 coding genes (GAS6, PSD3, PLCB4, DEXI, JMY, NRP1, C10orf55) and 3 long noncoding RNAs. In multivariable analysis, the 10-gene signature was strongly associated with relapse (P < .001), after adjustment for the FLT3-ITD, CEBPA, and NPM1 mutational status. Validation of the expression signature in an independent patient set from The Cancer Genome Atlas showed the signature's strong predictive value, with AUC = 0.78. Implementation of the 10-gene signature into clinical prognostic stratification could be useful for identifying patients who are likely to relapse.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Walker CJ, Mrózek K, Ozer HG, et al. Gene expression signature predicts relapse in adult patients with cytogenetically normal acute myeloid leukemia. Blood Adv. 2021. PMID: 33683341. doi:10.1182/bloodadvances.2020003727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。